Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page

Home > Past Science Meetings    

New Dynamics of HIV Risk Among Drug-Using Men Who Have Sex With Men

Bethesda, Maryland
March 1-2, 2004

NIDA Organizer(s): Jacques Normand and Elizabeth Lambert

Purpose & Intent

The purpose of the Workshop was to convene NIDA researchers and experts in HIV/AIDS and drug abuse to review and discuss information and findings from currently-funded NIDA grants that focus on HIV/AIDS and drug-using men who have sex with other men (MSM). In addition, the Workshop provided a forum for discussion and recommendations to guide the development of an innovative program of research on the changing dynamics of HIV risks among drug-using MSM and behavioral prevention/intervention strategies to address them.

Meeting Outcome

Over the 2-day workshop, participants discussed their research and findings, and the implications for public health interventions to prevent and treat HIV/AIDS among drug-using MSM. The Workshop also focused on gaps in our understanding of the changing epidemiology, HIV risk behaviors, and prevention practices among MSM today. Today, there appear to be at least four change agents that are impacting drug-using MSM simultaneously: Viagra is extending the length of the sexually active time period in a life course and is increasing the number of high-risk sexual encounters. The Internet is collapsing the spatial and temporal distance between people, which can lead to an increase in the rate of transmission of STDs. Sex-for-drugs or money appears to be increasing among MSM. And, while antiretroviral therapy is extending the lives of the highest risk members of subpopulations, it is also helping to keep them sexually active. Yet, while the convergence of these and other factors may be important for understanding the dynamics of HIV risks among drug-using MSM, it is equally important to recognize that MSM are diverse, and not all at equal risk. Recognizing variations in risk among MSM is important for formulating improved HIV interventions that are targeted, effective, and cost efficient. The need for HIV interventions that are seamless in offering both substance abuse and HIV treatment simultaneously is needed. As an entity in and of itself, the community also holds great promise for community-wide HIV outreach prevention campaigns that focus on the diffusion of pro-social norms, positive behavior change, and preventing drug use and high-risk sexual behaviors.

Most of the workshop participants are finishing current studies, will submit or have submitted new research applications that address HIV & other infectious diseases among high-risk, drug-using MSM.

Resulting Publications

A special issue of the Journal of Urban Health is now in preparation as a result of Workshop. This journal reaches a broad and multidisciplinary audience that shares a common interest in understanding dynamic patterns of disease and the social, environmental, biological, and behavioral factors that influence them. The special issue is intended to provide national and international epidemiologists, drug abuse researchers, and healthcare professionals with current perspectives on new dynamics of risks for HIV/AIDS and other infections among drug-using men who have sex with men, while also informing the future HIV/AIDS and drug abuse research agenda.

Participants List

Patricia Case, Ph.D.
Harvard Medical School
Department of Social Medicine

641 Huntington Avenue
Boston, MA 02115
617-432-2565 (fax)

Michael C. Clatts, Ph.D., Director
Institute for International Research on Youth at Risk
National Development & Research Institutes, Inc.

71 West 23rd. Street, 4th Floor
New York, NY 10010
Ph. 212.845.4459
Fx. 917.438.0894

Grant Colfax, M.D.
Director of HIV Prevention Studies
HIV Research Branch
San Francisco Department of Public Health

25 Van Ness Avenue, Suite 710
San Francisco, CA 94102
415-554-9173 Office
415-431-7029 Fax

Rafael Diaz, Ph.D.
Center for Community Research
San Francisco State University

3004 16th St., Suite 301
San Francisco, CA 94103
ph: 415-522-5808
fax: 415-522-5899

Isabel M. Fernandez, Ph.D.
University of Miami
Dept of Epidemiology & Public Health

P.O. Box 016069 (R-669)
Miami, Fl 33101
Ph: (305) 243-2630
Fax: (305) 243-2634

Crystal Fuller, Ph.D.
Columbia University
Mailman School of Public Health

600 West 168th Street
New York, N.Y. 10032
Ph: (212) 342-0534
Fx: (212) 342-1824

Perry Halkitis, Ph.D.
Department of Applied Psychology
New York University

239 Greene Street East 537G
New York, NY 10003
Ph: 212.998.5373
Fax: 212.995.3654

William C. Holmes, M.D., M.S.C.E.
Division of General Internal Medicine
Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania School of Medicine

733 Blockley Hall
423 Guardian Drive
Philadelphia, PA 19104-6021
Ph: (215) 898-8188
Fax: (215) 573-2346

David Kanouse, Ph.D.
RAND Corporation
1700 Main Street
Santa Monica, CA 90407-2138
Ph: (310) 451-6963
Fax: (310) 451-6957

Alex Kral, Ph.D.
Dept of Family and Community Medicine
University of California, San Francisco

3180 18th Street Suite 302
San Francisco, CA 94110
Ph: 415-502-7221
Fax: 415-476-3406

Maureen Miller, Ph.D.
Columbia University
Division of Epidemiology

600 West 168 Street
New York, NY 10032
212-305-9413 (fax)

Jonathan Morgenstern, Ph.D.
Mount Sinai School of Medicine
One Gustave L. Levy Place

New York, NY 10029-6574
Ph: 212-659-8722
Fax: 212-849-2455

Thomas L. Patterson, Ph.D.
University of California at San Diego
Department of Psychiatry 0680

9500 Gilman Dr.
La Jolla CA 92093
Ph. 858- 534-3354
Fx. 858- 534-7723

Steven Shoptraw, Ph.D.
11075 Santa Monica Blvd.
Suite 200
Los Angeles, CA 90025
Ph: 310-312-0500 ext.351
Fax: 310-312-0552

Mark Williams, Ph.D.
University of Texas-Houston
School of Public Health
1200 Herman Pressler, RAS W906
Houston, TX 77030
(713) 500-9674
(713) 500-9602 (FAX)

Federal Government Participants

Sevgi Aral, Ph.D. (discussant)
Associate Director for Science

Centers for Disease Control and Prevention
1600 Clifton Rd.
Mailstop E02
Atlanta, GA 30333
404-639-8259 (phone)
404-639-8608 (fax)

Ronald Stall, Ph.D. (discussant)
Director, BIRB

Centers for Disease Control and Prevention
1600 Clifton Rd.
Mailstop E37
Atlanta, GA 30333
404-639-4937 (phone)
404-639-1950 (fax)

Elizabeth Y. Lambert, M. Sc. (Co-chair)
Center on AIDS and Other Medical Consequences of Drug Abuse
National Institute on Drug Abuse

6001 Executive Blvd.
Room 5198 MSC 9593
Bethesda, MD 20892
301-480-4544 (fax)

Jacques L. Normand, Ph.D. (Chair)
Center on AIDS and Other Medical Consequences of Drug Abuse
National Institute on Drug Abuse

6001 Executive Blvd.
Room 5198 MSC 9593
Bethesda, MD 20892
301-480-4544 (fax)

Helen K. Cesari, M.Sc.
Special Assistant to the Deputy Director
National Institute on Drug Abuse

6001 Executive Blvd.
6001 Executive Blvd. Rm 5274
Bethesda, MD 20892-9581

What's New Contents

Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal